View of Safety and Efficacy of Oral Brivaracetam versus Levetiracetam as Monotherapy in Children Aged 1 Month to 14 Years with Newly Diagnosed Epilepsy

Return to Article Details Safety and Efficacy of Oral Brivaracetam versus Levetiracetam as Monotherapy in Children Aged 1 Month to 14 Years with Newly Diagnosed Epilepsy Download Download PDF